OK I read it. No start announced. Recall that Leo has been talking about this trial since April 6 2020 and said for sure q4 start many times. Many here said this q4 start was guaranteed.
Oh well. it's biotech, right?
Why should we believe January start?
The pace of research over the summer and the failure to move forward quickly has been horrendous. Leo lost all momentum.
A big pharma partner woulda meant otherwise, but it never materialized.
If B succeeds in the trial it will be a miracle and all here will have shares worth 10-100x today. It is asking a lot.